SCHEMBL6005443

SCHEMBL6005443

CCCS(=O)(=O)OS(C)(=O)=O

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.33
TSHR P16473 2/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MMP9 P14780 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL576001 0.85 CA1 (0.33) TSHRALDH1A1LMNAMMP9
SCHEMBL29128556 0.84 ALDH1A1 (0.39) USP2TSHRKDM4EALDH1A1LMNA
SCHEMBL18126472 0.80 USP2 (0.39) USP2TSHRKDM4EALDH1A1LMNA
SCHEMBL1043228 0.79 USP2 (0.39) USP2TSHRKDM4EALDH1A1LMNA
SCHEMBL18126379 0.78 FAAH (0.39) ALDH1A1LMNA
SCHEMBL18126342 0.78 USP2 (0.38) USP2TSHRKDM4EALDH1A1LMNA
SCHEMBL18126397 0.76 FAAH (0.42)
SCHEMBL15868137 0.76 CA2 (0.32) TSHR
SCHEMBL11195053 0.76 LMNA (0.38) USP2TSHRKDM4EALDH1A1LMNA
SCHEMBL18126340 0.76 FAAH (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105130986-B Pyrimidine or pyridopyridine ketone compounds and its application 广州科擎新药开发有限公司 2017-07-18 CN disclosed
CN-105130986-A Pyrimidine or pyridino-pyridone compound and application thereof GUANGZHOU KEQIN NEW MEDICINE DEV CO LTD 2015-12-09 CN disclosed
CN-104151216-A Synthetic method of lapatinib side chain SHANDONG BOYUAN PHARMACEUTICAL CO LTD 2014-11-19 CN disclosed
EP-1406869-B1 TAXOL ENHANCER COMPOUNDS SYNTA PHARMACEUTICALS CORP (US) 2006-09-13 EP disclosed
CN-1143856-C Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) [1,4] diazepan-1-yl)-1-(aryl) butyl) benzamides useful for treatment of allergic diseases ���µ�˹ҩ�﹫˾ 2004-03-31 CN disclosed
CN-1115341-C Novel substituted N-methyl-N- (4- (4- (1H-benzimidazol-2-ylamino) piperidin-1-yl) -2- (aryl) butyl) benzamides for the treatment of allergic diseases AVENTIS PHARMACEUTICALS CORP (US) 2003-07-23 CN disclosed
CN-1080262-C Novel substituted 4-(1H-benzimidazol-2-YL) [1,4] diazepanes useful for the treatment of allergic diseases HOECHST MARION ROUSSEL INC (US) 2002-03-06 CN disclosed
CN-1211246-A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases HOECHST MARION ROUSSEL INC (US) 1999-03-17 CN disclosed
CN-1211248-A Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) [1,4] diazepan-1-yl)-1-(aryl) butyl) benzamides useful for treatment of allergic diseases HOECHST MARION ROUSSEL INC (US) 1999-03-17 CN disclosed
CN-1207097-A Novel substituted 4- (1H-benzimidazol-2-yl) [1,4] diazepanes useful for the treatment of allergic diseases HOECHST MARION ROUSSEL INC (US) 1999-02-03 CN disclosed
WO-1998008508-A1 USE OF PKC INHIBITORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HTLV-1 INFECTIONS ELI LILLY AND COMPANY (US) 1998-03-05 WO disclosed
EP-0165784-B1 ISOXAZOLE AND ISOTHIAZOLE DERIVATIVES ELI LILLY AND COMPANY (US) 1989-11-23 EP disclosed
US-4001247-A 1-ETHYL 3A-(SUBSTITUTED-PHENYL) DECAHYDROISOQUINOLINE ELI LILLY AND COMPANY (US) 1977-01-04 US disclosed